University Park, Pennsylvania — The Pennsylvania State Council’s Commission on Finance, Business, and Capital Planning advanced a $37.3 million initiative for renovation and expansion. Pennsylvania State Medical CollegeComparative medicine facility today (September 22nd). The entire Board will consider this proposal on September 23rd.
For the past two years, the medical school has been Penn State’s top externally funded university. Most of the multi-year awards held by the university come from a combination of federal, association, and industry programs, worth more than $70 million, and use model organisms to study cancer, aging, infectious diseases, It relies on comparative medicine laboratories to study substances. Use Disabilities and Other Health Conditions. The proposed renovation and expansion plans will modernize these research spaces and improve research capabilities in both adult and childhood cancers, as well as support a range of research into the causes and treatments of other medical conditions.
“The board’s support for this initiative recognizes the medical school’s continued growth as a premier destination for biomedical and health science research in the region. Ronald Wilson, Professor and Chair of the Department of Comparative Medicine. “This project will provide faculty, staff and students with the ability to improve human health through research in state-of-the-art modern facilities.”
The medical school secured $12.2 million in funding from Four Diamonds to advance childhood cancer research and $5 million in funding from Pennsylvania’s Redevelopment Assistance Capital Program to support the project. The project is expected to begin this fall and finish by mid-2024, using plans developed by HDR Inc. of Lawrenceville, NJ.
The project includes the renovation of approximately 11,000 square feet of existing research space and the addition of 18,700 square feet of new space. This project will modernize the imaging facility and establish the first sterile research facility on campus. This is important to support university microbiome research initiatives. Additionally, this project will enhance the university’s ability to develop implantable devices and become a leader in translational research, as outlined in the university’s strategic plan.
